End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
3.39
CNY
|
-1.17%
|
|
+10.42%
|
-29.96%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,708
|
1,678
|
1,270
|
1,619
|
1,594
|
2,382
|
Enterprise Value (EV)
1 |
1,660
|
1,623
|
1,258
|
1,600
|
1,588
|
2,382
|
P/E ratio
|
174
x
|
-24.4
x
|
-36.9
x
|
-165
x
|
-46.3
x
|
-53.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.29
x
|
5.55
x
|
6.46
x
|
6.13
x
|
8.93
x
|
16.9
x
|
EV / Revenue
|
4.17
x
|
5.36
x
|
6.4
x
|
6.06
x
|
8.89
x
|
16.9
x
|
EV / EBITDA
|
126
x
|
-64.1
x
|
-36.3
x
|
-624
x
|
-52
x
|
-59.9
x
|
EV / FCF
|
134
x
|
27
x
|
-34.5
x
|
120
x
|
-987
x
|
206
x
|
FCF Yield
|
0.75%
|
3.71%
|
-2.9%
|
0.84%
|
-0.1%
|
0.49%
|
Price to Book
|
4.72
x
|
5.69
x
|
4.89
x
|
6.47
x
|
7.32
x
|
13.6
x
|
Nbr of stocks (in thousands)
|
492,089
|
492,089
|
492,089
|
492,089
|
492,089
|
492,089
|
Reference price
2 |
3.470
|
3.410
|
2.580
|
3.290
|
3.240
|
4.840
|
Announcement Date
|
4/24/19
|
5/19/20
|
4/14/21
|
3/30/22
|
4/29/23
|
4/19/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
397.8
|
302.6
|
196.6
|
263.9
|
178.6
|
141
|
EBITDA
1 |
13.18
|
-25.32
|
-34.68
|
-2.562
|
-30.53
|
-39.74
|
EBIT
1 |
3.551
|
-55.52
|
-44
|
-11.25
|
-38.03
|
-46.17
|
Operating Margin
|
0.89%
|
-18.35%
|
-22.38%
|
-4.26%
|
-21.29%
|
-32.76%
|
Earnings before Tax (EBT)
1 |
12.1
|
-63.34
|
-35.06
|
-9.215
|
-33.77
|
-43.33
|
Net income
1 |
11.01
|
-67.64
|
-35.48
|
-9.34
|
-32.29
|
-43.36
|
Net margin
|
2.77%
|
-22.36%
|
-18.05%
|
-3.54%
|
-18.08%
|
-30.76%
|
EPS
2 |
0.0200
|
-0.1400
|
-0.0700
|
-0.0200
|
-0.0700
|
-0.0900
|
Free Cash Flow
1 |
12.42
|
60.21
|
-36.43
|
13.37
|
-1.609
|
11.55
|
FCF margin
|
3.12%
|
19.9%
|
-18.53%
|
5.07%
|
-0.9%
|
8.2%
|
FCF Conversion (EBITDA)
|
94.27%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
112.81%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/24/19
|
5/19/20
|
4/14/21
|
3/30/22
|
4/29/23
|
4/19/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
47.1
|
54.8
|
11.6
|
18.9
|
5.95
|
0.14
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
12.4
|
60.2
|
-36.4
|
13.4
|
-1.61
|
11.6
|
ROE (net income / shareholders' equity)
|
3.1%
|
-20.7%
|
-12.9%
|
-3.68%
|
-13.9%
|
-22.2%
|
ROA (Net income/ Total Assets)
|
0.42%
|
-6.76%
|
-5.95%
|
-1.64%
|
-6.36%
|
-9.19%
|
Assets
1 |
2,644
|
1,001
|
596.7
|
570
|
507.6
|
471.9
|
Book Value Per Share
2 |
0.7300
|
0.6000
|
0.5300
|
0.5100
|
0.4400
|
0.3500
|
Cash Flow per Share
2 |
0.1900
|
0.1500
|
0.1400
|
0.1300
|
0.1100
|
0.0900
|
Capex
1 |
4.87
|
5.69
|
0.78
|
3.22
|
1.26
|
0.14
|
Capex / Sales
|
1.22%
|
1.88%
|
0.39%
|
1.22%
|
0.71%
|
0.1%
|
Announcement Date
|
4/24/19
|
5/19/20
|
4/14/21
|
3/30/22
|
4/29/23
|
4/19/24
|
|
1st Jan change
|
Capi.
|
---|
| -29.96% | 230M | | +9.12% | 33.76B | | +13.75% | 7.72B | | +5.75% | 7.03B | | +18.54% | 5.36B | | -3.97% | 4.14B | | +38.58% | 4.07B | | +15.30% | 3.77B | | +4.48% | 3.42B | | -11.92% | 2.64B |
Testing & Measuring Equipment
|